Table 4 Prescription of G-CSF
From: Febrile neutropenia in French emergency departments: results of a prospective multicentre survey
Variables | Number (%) |
|---|---|
Prophylactic prescription of G-CSF before referral in ED | 47 (24) |
Age >65 years | 14 (30) |
Recurrent or resistant cancer | 28 (60) |
Chemotherapy at high-risk for neutropenia (risk >20%) | 15 (38) |
Previous history of febrile neutropenia | 15 (32) |
Prescription of G-CSF initiated in ED | 27 (19) |
Patients with severe sepsis | 12 (44) |